La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
TransMedics Group Bilan de santé
Santé financière contrôle des critères 2/6
TransMedics Group possède un total de capitaux propres de $189.9M et une dette totale de $507.8M, ce qui porte son ratio d'endettement à 267.4%. Son actif total et son passif total sont $758.6M et de $568.7M. L'EBIT de TransMedics Group est $28.4M ce qui fait que son ratio de couverture des intérêts -11.9. Elle dispose de liquidités et de placements à court terme de $362.8M.
Informations clés
267.4%
Ratio d'endettement
US$507.75m
Dette
| Ratio de couverture des intérêts | -11.9x |
| Argent liquide | US$362.75m |
| Fonds propres | US$189.89m |
| Total du passif | US$568.68m |
| Total des actifs | US$758.58m |
Mises à jour récentes de la santé financière
Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 11
Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?
Nov 05TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?
Aug 02Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 27Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?
Jan 16Recent updates
TransMedics: Heart And Lungs Will Drive The Next Leg Higher
Aug 19Analysts Just Made A Meaningful Upgrade To Their TransMedics Group, Inc. (NASDAQ:TMDX) Forecasts
Aug 06TransMedics Group: Providing Long-Term Detailed Forecast And Upgrading To Buy
Aug 04TransMedics Group, Inc. Just Recorded A 66% EPS Beat: Here's What Analysts Are Forecasting Next
Aug 02TransMedics Group Stock: Too Far, Too Fast
Jul 08TransMedics: NOP, Logistics And Transport Are Key Growth Drivers But Stock Is Pricey
Jun 17TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger
Jun 10TransMedics: Transportation Supporting Growth
May 21TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)
May 06TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Apr 24TransMedics Group: Founder Led Company With Solid Potential
Apr 19Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 11TransMedics Group: Emerging Medical Device Market Leader With A Long Growth Runway
Mar 19TransMedics Group: Huge Opportunity In Organ Transplants
Mar 12TransMedics: A Very Expensive Growth Stock
Feb 07With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For
Jan 23Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
Jan 02Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?
Nov 05This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year
Aug 06TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?
Aug 02TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing
Jun 29Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts
May 06Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 27Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
Apr 09Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?
Jan 16Analyse de la situation financière
Passif à court terme: Les actifs à court terme de TMDX ( $509.3M ) dépassent ses passifs à court terme ( $54.3M ).
Passif à long terme: Les actifs à court terme de TMDX ( $509.3M ) ne couvrent pas ses passifs à long terme ( $514.4M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de TMDX ( 76.4% ) est considéré comme élevé.
Réduire la dette: Le ratio d'endettement de TMDX est passé de 47.7% à 267.4% au cours des 5 dernières années.
Couverture de la dette: La dette de TMDX n'est pas bien couverte par le flux de trésorerie opérationnel ( 4.7% ).
Couverture des intérêts: TMDX gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.